Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Sianos, Michail Papafaklis, J. Daemen, S. Vaina, C. Mieghem, R. Domburg, L. Michalis, P. Serruys (2007)
Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden.Journal of the American College of Cardiology, 50 7
B. Lagerqvist, Ole Fröbert, G. Olivecrona, T. Gudnason, M. Maeng, P. Alström, J. Andersson, F. Calais, J. Carlsson, O. Collste, Matthias Götberg, P. Hårdhammar, D. Ioanes, A. Kallryd, R. Linder, A. Lundin, J. Odenstedt, E. Omerovic, V. Puskár, T. Tödt, Eva Zelleroth, O. Östlund, S. James (2014)
Outcomes 1 year after thrombus aspiration for myocardial infarction.The New England journal of medicine, 371 12
G. Stone (2012)
Simple aspiration in acute myocardial infarction: too simple to be true?European heart journal, 33 24
A. Bavry, D. Kumbhani, Deepak Bhatt (2008)
Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials.European heart journal, 29 24
Ole Fröbert, B. Lagerqvist, G. Olivecrona, E. Omerovic, T. Gudnason, M. Maeng, M. Aasa, O. Angerås, F. Calais, Mikael Danielewicz, D. Erlinge, Lars Hellsten, Ulf Jensen, Agneta Johansson, Amra Kåregren, J. Nilsson, L. Robertson, L. Sandhall, I. Sjögren, O. Ostlund, J. Harnek, S. James (2013)
Thrombus aspiration during ST-segment elevation myocardial infarction.The New England journal of medicine, 369 17
T. Svilaas, P. Vlaar, I. Horst, G. Diercks, B. Smet, A. Heuvel, R. Anthonio, G. Jessurun, E. Tan, A. Suurmeijer, F. Zijlstra (2008)
Thrombus aspiration during primary percutaneous coronary intervention.The New England journal of medicine, 358 6
F. Imola, M. Mallus, V. Ramazzotti, A. Manzoli, L. Vito, M. Occhipinti, A. Cremonesi, E. Arbustini, F. Prati, M. Albertucci (2015)
Quantification of manual thrombus removal in patients with acute coronary syndromes: a study exploiting serial frequency domain-optical coherence tomographyJournal of Cardiovascular Medicine, 16
S. Jolly, J. Cairns, S. Yusuf, Brandi Meeks, J. Pogue, M. Rokoss, S. Kedev, L. Thabane, G. Stanković, R. Moreno, A. Gershlick, S. Chowdhary, S. Lavi, K. Niemelä, P. Steg, I. Bernat, Yawei Xu, W. Cantor, C. Overgaard, C. Naber, A. Cheema, R. Welsh, O. Bertrand, Á. Avezum, R. Bhindi, S. Pancholy, S. Rao, M. Natarajan, J. Berg, O. Shestakovska, P. Gao, P. Widimsky, V. Džavík (2015)
Randomized trial of primary PCI with or without routine manual thrombectomy.The New England journal of medicine, 372 15
P. Vlaar, T. Svilaas, I. Horst, G. Diercks, M. Fokkema, B. Smet, A. Heuvel, R. Anthonio, G. Jessurun, E. Tan, A. Suurmeijer, F. Zijlstra (2008)
Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up studyThe Lancet, 371
Objectives To describe the first‐in‐man experience with the ClearLumen Thrombectomy System (Walk Vascular, Irvine, CA) and report on its safety, feasibility and efficacy when used as an adjunctive therapy during primary PCI. Background Thrombus aspiration (TA) aims to improve microvascular perfusion but currently available devices are not optimal. Methods Prospective, single‐centre, non‐randomized, safety, and efficacy trial. Patients with acute STEMI were enrolled and the investigational device was used for thrombus aspiration. Safety was evaluated as the overall rate of device related complications while efficacy as the rate of successful device deployment and culprit vessel reperfusion. The composite endpoint based on the achievement of at least two of the following three criteria—TIMI flow 3 and/or myocardial blush grade ≥2 at completion of the case and ST‐resolution >70% at 90 minutes after vessel reperfusion—was also evaluated. Results Over a 3 months period 20 patients were enrolled in the study. Culprit lesion was successfully reached with the investigational device in 19 patients (95%). The pre‐specified combined endpoint was met in 16 out of 19 patients (84.2%). Three patients not meeting the combined end point had procedure related, non TA associated, adverse event. Only 2 minor procedural adverse event occurred after thrombus aspiration. Conclusions This first‐in‐man experience with the ClearLumen Thrombectomy System demonstrates initial promising results on safety and efficacy when used as an adjunctive therapy during primary PCI. (J Interven Cardiol 2016;29:155–161)
Journal of Interventional Cardiology – Wiley
Published: Apr 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.